This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milani, S. Articles by Surrenti, C. Search for Related Content PubMed PubMed Citation Articles by Milani, S. Articles by Surrenti, C.

American Journal of Pathology, Vol 139, 1221-1229, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease

S Milani, H Herbst, D Schuppan, H Stein and C Surrenti
Department of Clinical Physiopathology, University of Florence, Italy.

Transforming growth factor (TGF) beta 1 has been implicated in the control of hepatocyte growth and stimulation of extracellular matrix synthesis in acute and chronic liver disease. The cellular localization of transforming growth factor (TGF) beta 1 and beta 2 RNA transcripts was determined in normal and fibrotic liver by in situ hybridization with [35S]-labeled RNA probes in combination with immunostaining for cell type characteristic markers. Fibrotic specimens were from patients with hepatitis B virus infection or alcohol abuse and rats with fibrosis secondary to bile duct ligation and scission. In normal liver, low levels of TGF beta 1 transcripts were found in some portal tract stromal cells, and TGF beta 2 RNA was not detectable. In fibrotic liver, high TGF beta 1 RNA levels were present in most mesenchymal liver cells, in most inflammatory cells, and in few bile duct epithelial cells. Hepatocytes did not express this cytokine with the exception of few limiting plate hepatocytes in cases of human cirrhosis with high activity. TGF beta 2 transcripts were detected at high levels in proliferating bile ducts of fibrotic livers, but were absent in all other cell types. TGF beta 1 expression in the liver is thus a function predominantly of mononuclear and mesenchymal cells as well as of some hepatocytes, whereas TGF beta 2 expression is a specific property of bile duct epithelial cells that may be related to the formation of specialized periductular connective tissue during bile duct proliferation.

This article has been cited by other articles:

				Y. Sato, K. Harada, K. Kizawa, T. Sanzen, S. Furubo, M. Yasoshima, S. Ozaki, M. Ishibashi, and Y. Nakanuma Activation of the MEK5/ERK5 Cascade Is Responsible for Biliary Dysgenesis in a Rat Model of Caroli's Disease Am. J. Pathol., January 1, 2005; 166(1): 49 - 60. [Abstract] [Full Text] [PDF]

				R Sato, C Maesawa, K Fujisawa, K Wada, K Oikawa, Y Takikawa, K Suzuki, H Oikawa, K Ishikawa, and T Masuda Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis Gut, July 1, 2004; 53(7): 1001 - 1009. [Abstract] [Full Text] [PDF]

				Z. Zhong, M. Froh, M. Lehnert, R. Schoonhoven, L. Yang, H. Lind, J. J. Lemasters, and R. G. Thurman Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G1004 - G1013. [Abstract] [Full Text] [PDF]

				T. V. Masyuk, E. L. Ritman, and N. F. LaRusso Hepatic Artery and Portal Vein Remodeling in Rat Liver: Vascular Response to Selective Cholangiocyte Proliferation Am. J. Pathol., April 1, 2003; 162(4): 1175 - 1182. [Abstract] [Full Text] [PDF]

				R Jaster, G Sparmann, J Emmrich, and S Liebe Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells Gut, October 1, 2002; 51(4): 579 - 584. [Abstract] [Full Text] [PDF]

				N A Shackel, P H McGuinness, C A Abbott, M D Gorrell, and G W McCaughan Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression Gut, October 1, 2001; 49(4): 565 - 576. [Abstract] [Full Text] [PDF]

				N. Sedlaczek, J.-D. Jia, M. Bauer, H. Herbst, M. Ruehl, E. G. Hahn, and D. Schuppan Proliferating Bile Duct Epithelial Cells Are a Major Source of Connective Tissue Growth Factor in Rat Biliary Fibrosis Am. J. Pathol., April 1, 2001; 158(4): 1239 - 1244. [Abstract] [Full Text] [PDF]

				M. Bustos, B. Sangro, P. Alzuguren, A. G. Gil, J. Ruiz, N. Beraza, C. Qian, A. Garcia-Pardo, and J. Prieto Liver Damage using Suicide Genes : A Model for Oval Cell Activation Am. J. Pathol., August 1, 2000; 157(2): 549 - 559. [Abstract] [Full Text] [PDF]

				L. G. Kömüves, A. Feren, A. L. Jones, and E. Fodor Expression of Epidermal Growth Factor and Its Receptor in Cirrhotic Liver Disease J. Histochem. Cytochem., June 1, 2000; 48(6): 821 - 830. [Abstract] [Full Text]

				L. Fabris, M. Strazzabosco, H. A. Crosby, G. Ballardini, S. G. Hubscher, D. A. Kelly, J. M. Neuberger, A. J. Strain, and R. Joplin Characterization and Isolation of Ductular Cells Coexpressing Neural Cell Adhesion Molecule and Bcl-2 from Primary Cholangiopathies and Ductal Plate Malformations Am. J. Pathol., May 1, 2000; 156(5): 1599 - 1612. [Abstract] [Full Text] [PDF]

				K. L. Rudolph, S. Chang, M. Millard, N. Schreiber-Agus, and R. A. DePinho Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery Science, February 18, 2000; 287(5456): 1253 - 1258. [Abstract] [Full Text]

				J. George, S.-S. Wang, A.-M. Sevcsik, M. Sanicola, R. L. Cate, V. E. Koteliansky, and D. M. Bissell Transforming Growth Factor-{beta} Initiates Wound Repair in Rat Liver through Induction of the EIIIA-Fibronectin Splice Isoform Am. J. Pathol., January 1, 2000; 156(1): 115 - 124. [Abstract] [Full Text] [PDF]

				V. L. Barnes, J. Musa, R. J. Mitchell, and J. L. Barnes Expression of Embryonic Fibronectin Isoform EIIIA Parallels {alpha}-Smooth Muscle Actin in Maturing and Diseased Kidney J. Histochem. Cytochem., June 1, 1999; 47(6): 787 - 798. [Abstract] [Full Text]

				S. Kanzler, A. W. Lohse, A. Keil, J. Henninger, H. P. Dienes, P. Schirmacher, S. Rose-John, K. H. Meyer Zum Buschenfelde, and M. Blessing TGF-beta 1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1059 - G1068. [Abstract] [Full Text] [PDF]

				Y. Kim, V. Ratziu, S.-G. Choi, A. Lalazar, G. Theiss, Q. Dang, S.-J. Kim, and S. L. Friedman Transcriptional Activation of Transforming Growth Factor beta 1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1. POTENTIAL MECHANISMS FOR AUTOCRINE FIBROGENESIS IN RESPONSE TO INJURY J. Biol. Chem., December 11, 1998; 273(50): 33750 - 33758. [Abstract] [Full Text] [PDF]

				G. A. Ramm, V. G. Nair, K. R. Bridle, R. W. Shepherd, and D. H. G. Crawford Contribution of Hepatic Parenchymal and Nonparenchymal Cells to Hepatic Fibrogenesis in Biliary Atresia Am. J. Pathol., August 1, 1998; 153(2): 527 - 535. [Abstract] [Full Text] [PDF]

				M. S. Anscher, W. P. Peters, H. Reisenbichler, W. P. Petros, and R. L. Jirtle Transforming Growth Factor {beta} as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer N. Engl. J. Med., June 3, 1993; 328(22): 1592 - 1598. [Abstract] [Full Text]